Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease
Yan Ye(Army Medical University), Xiaoming Zhang(Shanghai Medical College of Fudan University), Chunde Bao(Second Affiliated Hospital of Zhejiang University), Shuang Ye(Little Swan (China)), Qiong Fu(Shanghai Jiao Tong University), Runci Wang(Brigham and Women's Hospital), Teng Li(Institut Pasteur of Shanghai), Ran Wang(Renji Hospital), Xueliang Zhang(Chinese PLA General Hospital), Chunmei Wu(Shanghai Jiao Tong University), Jiaqiang Ma(Ministry of Education), Qiang Guo(Renji Hospital), Nan Shen(China-Japan Friendship Hospital)
Cited by 29
Related Papers
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
|Nature Metabolism|2023|540
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|387
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma
|Journal of Hepatology|2021|245